Search results
Minerva (NERV) Submits NDA for Schizophrenia Candidate, Stock Up
Zacks via Yahoo Finance· 2 years agoMinerva Neurosciences NERV submitted a new drug application (“NDA”) to the FDA seeking approval of...
Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with many important pipeline and regulatory updates. Collaboration...
Incyte (INCY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoIncyte Corporation INCY is scheduled to release its third-quarter 2022 results on Nov 1, before...
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
Zacks via Yahoo Finance· 2 days agoShares of Ovid Therapeutics OVID plunged 76% on Monday after it announced that treatment with...
Regeneron (REGN) Down on Ophthalmology Drug Eylea Sales Update
Zacks via Yahoo Finance· 1 year agoShares of Regeneron Pharmaceuticals, Inc. REGN were down 7.69% after the company announced that its...
Biogen's (BIIB) ALS Drug Tofersen Filing Accepted in Europe
Zacks via Yahoo Finance· 2 years agoBiogen BIIB announced that the European Medicines Agency (EMA) has accepted the marketing...
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN recently announced that its supplemental biologics License...
3 Biotech Stocks Aiming to Reinvent Mental Health Treatment
Zacks via Yahoo Finance· 2 years agoMental health issues are a growing concern in the United States. According to the National Institute...
Celebrities Who Died Broke (or Close to It)
Cheapism via AOL· 5 months agoKMazur / Contributor / Wireimage / Getty Images Stars Who Burned Through Their Cash Performers aren’t usually known for their money management skills, no...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 11 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...